Skip to main content
main-content

Devices and technology

News

08-08-2019 | Continuous glucose monitoring | News

Pros and cons of CGM described by parents of children with diabetes

Continuous glucose monitoring offers many benefits to the families of young children with type 1 diabetes but also a number of challenges that cannot always be overcome, show results of a qualitative analysis conducted in the USA.

07-23-2019 | Artificial pancreas systems | News

Medtronic closed-loop system with bolus correction promising in first clinical trial

The latest iteration to the Medtronic artificial pancreas system, which includes automated correction boluses, shows promising results in its first home-based trial.

07-12-2019 | Continuous glucose monitoring | Highlight | News

CGM measures have variable correlation with HbA1c

Glycated hemoglobin levels correlate strongly with continuous glucose monitoring-measured average blood glucose and hyperglycemia, but poorly with hypoglycemia, say researchers.

07-05-2019 | Continuous glucose monitoring | News

ATTD consensus group releases time in range recommendations

A statement from an ATTD consensus group has streamlined previously agreed continuous glucose monitoring metrics and set out time in range targets.

06-11-2019 | Hypoglycemia | ADA 2019 | News

CGM data can predict future severe hypoglycemia

Most hypoglycemia outcomes measured by real-time continuous glucose monitoring can be used to predict future severe hypoglycemia in people with type 1 diabetes, with similar levels of accuracy, study findings indicate.

05-31-2019 | Children | News

High variability in insulin needs complicates diabetes management in young children

Children with type 1 diabetes who are aged 6 years or younger have significantly more variability in their insulin needs than adolescents or adults, shows an analysis of closed-loop data.

05-29-2019 | Insulin pumps | News

Real-world data confirm benefits of ‘pump-suspend’ technology in diabetes

Exposure to hypoglycemia deceases significantly with increasing levels of insulin suspension automation in people with type 1 diabetes, real‐world study data show.

05-23-2019 | Type 1 diabetes | News

Treatment simplification a major unmet need in type 1 diabetes

People with type 1 diabetes have high-priority concerns that go beyond glucose control, including complex and mentally taxing treatment and weight gain, report researchers.

05-20-2019 | Continuous glucose monitoring | News

CGM still lags behind SMBG during aerobic exercise

Even with newer devices, continuous glucose monitoring underestimates the fall in glucose levels during exercise, with the drop lagging significantly behind that measured by self-monitoring of blood glucose, research shows.

05-09-2019 | Devices and technology | News

Support for patch delivery of bolus insulin in people with type 2 diabetes

Delivery of bolus insulin via a patch results in similar glycemic control to that delivered by a conventional pen, with improvements in treatment satisfaction and quality of life, findings from a randomized trial suggest.

05-01-2019 | Hypoglycemia | News

Hypoglycemia-prone adults benefit from suspend-before-low pump technology

People with type 1 diabetes at high hypoglycemia risk using insulin pumps have fewer hypoglycemic events if the pump is linked to a continuous glucose monitor and has a suspend-before-low feature, SMILE study data show.

04-18-2019 | Mobile technology | News

Study highlights ‘immaturity’ of diabetes self-management apps

A large proportion of mobile apps for self-management of blood glucose do not provide real-time decision support for users with type 2 diabetes, researchers report.

04-08-2019 | Flash glucose monitoring | News

Real-world benefits of flash glucose monitoring confirmed in high-risk cases

Flash glucose monitoring significantly reduces time in hyperglycemia or hypoglycemia in people with diabetes at high risk for either outcome, with the benefit sustained for at least 6 months, real-world study data show.

04-04-2019 | Insulin pumps | Highlight | News

Randomized trial questions superiority of insulin pumps over injections in children

Insulin pumps and multiple daily injections deliver similar glycemic control and safety profiles when allocated alongside education and support at the point of type 1 diabetes diagnosis, say researchers.

04-03-2019 | Continuous glucose monitoring | News

Real-world data support predictive low-glucose alerts for hypoglycemia avoidance

The frequency at which people with type 1 diabetes experience hypoglycemia decreases during the first 30 days after they switch to a continuous glucose monitor that incorporates a predictive low-glucose alert, research shows.

04-01-2019 | Artificial pancreas systems | News

Closed-loop insulin feasible for inpatients needing nutritional support

Researchers show that closed-loop insulin delivery achieves markedly better glucose control than standard insulin management in hospitalized patients with hyperglycemia receiving enteral or parenteral nutrition.

03-25-2019 | Artificial pancreas systems | News

Real-world data highlight closed-loop frustrations for youth users

System problems and irritations lead to nearly two in five children abandoning use of closed-loop insulin delivery in a real-world setting, researchers have reported.

03-25-2019 | Hypoglycemia | News

Problem of hypoglycemia unawareness highlighted in older people with type 1 diabetes

Baseline data from the WISDM trial show that older adults with type 1 diabetes who have impaired awareness of hypoglycemia symptoms can spend over half an hour per day with extremely low blood glucose levels.

03-13-2019 | Canagliflozin | DUKPC 2019 | News

ABCD audit data reveal improved glycemic control with use of FreeStyle Libre, canagliflozin

Analyses of real-world audit data show positive initial results for the flash glucose monitoring system FreeStyle Libre and the sodium-glucose cotransporter 2 inhibitor canagliflozin.

03-08-2019 | Pregnancy | DUKPC 2019 | News

CONCEPTT data show substantial cost savings with CGM in pregnancy

Using continuous glucose monitoring for all women with type 1 diabetes during pregnancy could save the UK National Health Service over 9 million pounds per year, report the CONCEPTT investigators.

02-28-2019 | Mobile technology | News

Engagement with mobile health intervention linked to improved glycemic control

Responsiveness to text message reminders about blood glucose monitoring is associated with glycemic benefit among adolescents with type 1 diabetes, study findings indicate.

02-28-2019 | Hypoglycemia | ATTD 2019 | News

Rechecking flash glucose monitor within the hour halves risk for prolonged hypoglycemia

Research shows that if people with diabetes recheck their glucose levels within 1 hour after receiving a low blood glucose alert from their flash glucose monitor it substantially reduces their risk for experiencing a long period of hypoglycemia.

02-26-2019 | Psychosocial care | ATTD 2019 | News

CGM at diabetes diagnosis improves family psychosocial outcomes

Giving children continuous glucose monitoring from the point of diabetes diagnosis gives their caregivers greater confidence to manage hypoglycemia and reduces their diabetes-related distress, shows a randomized trial.

02-25-2019 | Devices and technology | Highlight | News

d-Nav system helps people with type 2 diabetes optimize insulin doses

The d-Nav system, which calculates insulin dose adjustments according to glucose levels, can help people with type 2 diabetes achieve larger reductions in glycated hemoglobin levels than with healthcare professional support alone, shows a randomized trial in The Lancet.

02-19-2019 | Diabetic foot ulcers | News

Smartphone-based infrared camera accurately detects diabetic foot ulcers

A low-cost, smartphone-based infrared (IR) camera works as well as a high-end version for the detection of diabetic foot ulcers (DFU), study findings indicate.

02-15-2019 | Patient-reported outcomes | News

Gap between glycemic, patient-reported outcomes in HypoDE study

Continuous glucose monitoring has a less impressive effect on patient-reported outcomes than on glycemic control among patients with type 1 diabetes, reveal the HypoDE investigators.

02-14-2019 | Artificial pancreas systems | News

Artificial pancreas use viewed positively by users and caregivers

Daytime use of a day-and-night hybrid artificial pancreas system has a positive impact on the lives of users and their caregivers, show results of a longitudinal qualitative study.

02-01-2019 | Artificial pancreas systems | News

Support for hybrid closed-loop insulin delivery in young children

Home use of day and night hybrid closed-loop insulin delivery using the Cambridge model predictive control algorithm is feasible in children aged 1–7 years with type 1 diabetes, researchers report.

12-14-2018 | Artificial pancreas systems | News

MD-Logic closed-loop system successful for unmonitored day and night use

The DREAM5 randomized trial has confirmed the efficacy of closed-loop insulin delivery with the MD-logic algorithm in adolescents and young adults without remote monitoring.

12-13-2018 | Faster-acting insulin aspart | News

Fast-acting insulin aspart efficacy confirmed in CSII setting

Fast-acting insulin aspart is as effective as insulin aspart for glucose control when used for continuous subcutaneous insulin infusion in adults with type 1 diabetes, results of the onset 5 study show.

11-07-2018 | Pregnancy | News

Surprising CONCEPTT findings on insulin pumps versus injections in pregnant women

A prespecified analysis of the CONCEPTT trial shows that pregnant women with type 1 diabetes who were using pumps at baseline did not achieve as good glycemic control as those using multiple daily injections.

10-04-2018 | Artificial pancreas systems | EASD 2018 | News

‘Gold standard’ trial tests closed-loop delivery across the age spectrum

A randomized trial demonstrates the efficacy of closed-loop insulin delivery in a wide range of patients with poorly controlled type 1 diabetes.

08-22-2018 | Insulin pumps | News

Predictive insulin-suspend algorithm cuts hypoglycemia without consequent hyperglycemia

The Tandem Basal-IQ predictive low-glucose suspend insulin delivery system significantly reduces the proportion of time adults and children spend in hypoglycemia during 24-hour usage, show findings from the randomized crossover PROLOG trial.

07-31-2018 | Insulin pumps | News

Pros and cons of insulin pumps highlighted in young type 1 diabetes patients

Continuous subcutaneous insulin infusion therapy significantly lowers glycated hemoglobin levels in young people with type 1 diabetes, but at the cost of an increased risk for diabetic ketoacidosis during the first year, UK researchers report.

07-10-2018 | Artificial pancreas systems | ADA 2018 | News

OpenAPS user glycemic data reported

Patients with type 1 diabetes who move to a DIY closed-loop insulin delivery system have significant improvements in their glycemic control, shows an analysis of continuous glucose monitoring data.

07-05-2018 | Mobile technology | News

Automatic insulin titration improves glycemic control in type 2 diabetes

Insulin-dependent patients with type 2 diabetes using the d-Nav® system improve their glycemic control over and above that achieved with intensive healthcare professional support, research shows.

07-02-2018 | Artificial pancreas systems | ADA 2018 | News

Real-world MiniMed data in line with trial findings

Patients using the MiniMed 670G hybrid closed-loop system in the real world achieve similar glycemic control to patients who used it in the pivotal clinical trial, researchers have reported.

06-26-2018 | Artificial pancreas systems | Highlight | News

Closed-loop delivery improves inpatient glucose control in type 2 diabetes

Fully closed-loop insulin delivery results in a markedly improved time in range among inpatients with type 2 diabetes receiving noncritical care, researchers have reported.

06-24-2018 | Continuous glucose monitoring | ADA 2018 | News

Eversense glucose monitor accurate and popular for adolescent patients

Researchers have reported good accuracy, durability, and acceptability of the Eversense continuous glucose monitoring system in a group of primarily pediatric patients.

06-23-2018 | Children | ADA 2018 | News

Pubertal status affects glycemic variability in children with type 1 diabetes

Prepubertal children with type 1 diabetes have greater glycemic variability than those who are pubertal or postpubertal, researchers have reported at the ADA’s 78th Scientific Sessions.

06-14-2018 | Continuous glucose monitoring | News

Short-term CGM uncovers type 1 diabetes management issues

Just 1 week of continuous glucose monitoring can uncover hidden problems and lead to treatment changes and improved glucose control in patients with type 1 diabetes, say the DIACCOR study investigators.

05-22-2018 | Diabetes self-management | Highlight | News

Text message service helps support adults with diabetes self-care

A diabetes self-management support system delivered by text message may help patients to improve their glycemic control, shows a study in The BMJ.

05-16-2018 | Artificial pancreas systems | News

Glucagon in closed-loop system guards against exercise-induced hypoglycemia

Using a dual-hormone closed-loop insulin delivery system that detects when the wearer is doing exercise results in a low rate of exercise-induced hypoglycemia, show findings from a small randomized study.

04-27-2018 | Cystic fibrosis | News

HbA1c reflects blood glucose level in cystic fibrosis patients

Researchers have found that, contrary to received wisdom, glycated hemoglobin is an accurate guide to blood glucose levels in patients with cystic fibrosis.

04-18-2018 | Artificial pancreas systems | News

Data support artificial pancreas for type 1 diabetes, but better evidence needed

Analysis of the research to date comparing artificial pancreas treatment with other insulin systems supports its ability to significantly improve glycemic control in patients with type 1 diabetes, while reducing the burden of hypoglycemia.

04-18-2018 | Continuous glucose monitoring | News

CGM may be cost-effective in type 1 diabetes

Analysis of the DIAMOND study shows that continuous glucose monitoring in patients with type 1 diabetes could be considered cost-effective, although this depends on the value for money threshold used.

03-27-2018 | Pregnancy | News

Closed-loop insulin delivery shows promise in pregnancy

A small study suggests that closed-loop insulin delivery can produce equivalent glycemic control to that of sensor-augmented pump delivery, but with less hypoglycemia, during 1 month of use by pregnant women with type 1 diabetes.

02-21-2018 | Insulin pumps | News

Tubeless insulin pumps offer durable alternative to MDI in adolescents

Tubeless insulin pump use can provide long-term improvements in glycemic control at a lower total daily dose of insulin compared with multiple daily injections, show results of a retrospective study among children and young adults with type 1 diabetes.

02-19-2018 | Insulin pumps | News

More support for insulin pumps in type 2 diabetes

The results of a small study support the use of continuous subcutaneous insulin infusion for insulin-dependent patients with poorly controlled type 2 diabetes.

02-19-2018 | Continuous glucose monitoring | Highlight | News

HypoDE: CGM reduces hypoglycemia in high-risk patients using MDI

The HypoDE investigators have reported that use of continuous glucose monitoring results in large reductions in hypoglycemia among high-risk patients managing their type 1 diabetes with multiple daily injections.

02-16-2018 | Flash glucose monitoring | News

Hypoglycemia improvements seen with flash to CGM switch

Further findings from the pilot I-HART randomized trial suggest that switching from flash to continuous glucose monitoring reduces the time patients with type 1 diabetes spend in hypoglycemia

02-16-2018 | Flash glucose monitoring | News

Flash monitoring benefits backed up by real-world data

Flash glucose monitoring confers similar benefits for diabetes patients in the real world as for those using it in clinical trials, research shows.

02-06-2018 | Flash glucose monitoring | News

Care needed with flash glucose monitor placement

Not all sites on the body are equal when it comes to the placement of the FreeStyle® Libre™ flash glucose monitor on patients with type 1 diabetes, say researchers.

02-02-2018 | Disordered eating | News

Diet quality intervention does not trigger disordered eating in adolescents

Research shows that intervening to improve the diet quality of adolescents with type 1 diabetes does not exacerbate disordered eating behavior.

01-23-2018 | Continuous glucose monitoring | News

Real-world CGM data support better outcomes in type 1 diabetes

Research shows that continuous glucose monitoring reduces hypoglycemia risk and improves patient-reported outcomes among people with type 1 diabetes in real-world practice.

01-09-2018 | Hypoglycemia | News

Weight-based glucose best for tackling hypoglycemia in pump users

Taking a weight-based dose of glucose resolves hypoglycemia more effectively than taking a standard fixed dose for type 1 diabetes patients using an insulin pump, show the results of a randomized crossover trial.

12-19-2017 | Hypoglycemia | News

CGM may be better than flash for impaired hypoglycemia awareness

A pilot randomized study suggests that continuous glucose monitoring may be better than flash monitoring for reducing hypoglycemia in type 1 diabetes patients with impaired awareness.

12-18-2017 | Hypoglycemia | News

Severe hypoglycemia risk remains high years after previous episode in children with diabetes

The risk of having a repeat episode of severe hypoglycemia is elevated for at least 4 years after a previous episode in children with type 1 diabetes, although the risk is highest during the first year, researchers report.

12-14-2017 | Hypoglycemia | News

Automatic insulin pump suspension reduces hypoglycemia in adolescents with diabetes

Children and adolescents with type 1 diabetes using a predictive low-glucose management system have less hypoglycemia and fewer hypoglycemic events than those managed using sensor-augmented pump therapy alone, according to a 6-month trial.

11-17-2017 | Primary care | News

Care delivery variation affects glycemic control for type 1 diabetes patients

If all UK primary care practices operated to the standards of the top-performing centers there would be a marked nationwide increase in the proportion of patients with type 1 diabetes achieving glycemic control, say researchers.

11-07-2017 | Pregnancy | News

October Cochrane review round-up

The two diabetes-related Cochrane reviews published in October focused on diabetes during pregnancy; the first covered different methods of glucose monitoring, while the second compared oral antidiabetic agents with insulin, with both concluding that better quality research is needed to draw firm conclusions.

10-10-2017 | Insulin pumps | News

Real-world data support reduced hypoglycemia risk in young pump users

Findings from a population-based study indicate that insulin pump use is associated with reduced risks for severe hypoglycemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes.

09-29-2017 | Glycemic control | News

Web-based program benefits type 2 diabetes glycemic control

A web-based self-management program significantly improves glycemic control in people with type 2 diabetes compared with simple website information, UK trial findings suggest.

09-25-2017 | Flash glucose monitoring | Updates | News

Flash glucose monitoring system available on the NHS

The flash glucose monitoring system FreeStyle Libre has received approval to be listed on the NHS Drug Tariff for the management of diabetes from 1st November 2017.

09-15-2017 | Continuous glucose monitoring | EASD 2017 | News

CGM use during pregnancy improves maternal glycemic control, neonatal outcomes

The CONCEPTT trial results suggest that the use of continuous glucose monitoring by pregnant women with type 1 diabetes improves glycemic control and neonatal outcomes relative to standard glucose monitoring.

09-08-2017 | Artificial pancreas systems | News

Artificial pancreas stands up to intensive winter sports

Adolescents with type 1 diabetes attending a ski camp achieved better glycemic control with closed-loop control than with a sensor-augmented insulin pump, researchers report.

08-21-2017 | Continuous glucose monitoring | News

DIAMOND supports CGM in type 2 diabetes

Continuous glucose monitoring results in modest but significant improvements in glycemic control in patients with type 2 diabetes using basal–bolus insulin, show further results from the DIAMOND trial.

08-04-2017 | Gestational diabetes | News

Women with gestational diabetes are failing to self-monitor

More than a third of women with gestational diabetes are failing to self-monitor their postprandial blood glucose levels, with possible implications for pregnancy outcomes, according to a French pilot study.

07-21-2017 | Insulin pumps | News

Mixed results from adding insulin pump to CGM in type 1 diabetes

A analysis from the DIAMOND trial suggests that adding an insulin pump to continuous glucose monitoring leads to better glycemic control, but at the price of more hypoglycemia.

Read the linked commentary from Leonard Bertheau.

06-16-2017 | Glycemic control | News

Racial and individual variability in HbA1c–glucose relationship

Glycated hemoglobin levels are higher for a given blood glucose level in Black patients with diabetes than they are in White people, shows a continuous glucose monitoring study.

Read the linked commentary from Jay Shubrook.

05-24-2017 | Artificial pancreas systems | News

Meta-analysis supports artificial pancreas superiority over pumps

Artificial pancreas systems increase time in blood glucose target range by nearly 3 hours per day compared with conventional pump therapy in outpatients with type 1 diabetes, meta-analysis data show.

04-10-2017 | Continuous glucose monitoring | News

CGM could improve quality of life in patients with type 1 diabetes

Continuous glucose monitoring is associated with improvements in diabetes-specific quality of life compared with self-monitoring among patients with type 1 diabetes who use multiple daily insulin injections, study results suggest.

04-07-2017 | Continuous glucose monitoring | News

Predictive system reduces hypoglycemia burden in children with type 1 diabetes

Research suggests that a predictive low-glucose management system significantly reduces hypoglycemic events in children and adolescents with type 1 diabetes.

03-31-2017 | Glycemic control | News

Insulin pumps do not boost education effects on glycemic control

Research shows that switching to an insulin pump does not improve glycemic control in patients referred to an educational program after struggling to control their type 1 diabetes with multiple daily injections.

02-17-2017 | Continuous glucose monitoring | News

Findings support standalone use of CGM in well-controlled type 1 diabetes

Results of a randomized trial suggest that continuous glucose monitoring can be used without regular confirmatory blood glucose monitoring among adult insulin pump users with well-controlled type 1 diabetes.

01-24-2017 | Continuous glucose monitoring | News

CGM could aid glycemic control with multiple daily insulin injections

Two clinical trials published in JAMA show that continuous glucose monitoring can improve glycemic control in patients with type 1 diabetes who take insulin by means of multiple daily injections.

01-16-2017 | Artificial pancreas systems | News

Artificial pancreas benefits even well-controlled diabetes

Results of a randomized crossover trial show that closed-loop insulin delivery offers significantly improved glycemic control even in patients who are well controlled when self-monitoring their glucose levels.

12-23-2016 | Continuous glucose monitoring | News

Modest benefit found with real time continuous glucose monitoring

Real time continuous glucose monitoring is associated with a modest but significant reduction in glycosylated hemoglobin in patients with type 1 diabetes, but only if they are over 15 years of age, meta-analysis data show.

12-21-2016 | Artificial pancreas systems | News

Bihormonal artificial pancreas offers good glycemic control

Results of a randomized crossover trial suggest that a bihormonal artificial pancreas that can be used at home and is initialized only with body mass index provides good glycemic control among adults with type 1 diabetes.

12-05-2016 | Devices and technology | News

Physical barriers to device use highlighted in type 1 diabetes patients

Physical barriers such as discomfort and appearance can deter patients with type 1 diabetes from using glucose monitors and insulin pumps, show survey results.

11-16-2016 | Injection pens | Updates | News

Warning against extracting insulin from pen devices

NHS Improvement has issued a warning against healthcare professionals using insulin syringes and needles to extract insulin directly from pen devices or refill cartridges.

11-10-2016 | Artificial pancreas systems | News

Artificial pancreas could meet type 2 diabetes inpatient needs

A pilot randomized trial suggests that closed-loop insulin delivery is feasible for inpatients with insulin-dependent type 2 diabetes on the general ward.

10-06-2016 | Diagnosis | News

Researchers improve on blood glucose estimation

Accounting for the age of red blood cells strengthens the association between glycated haemoglobin and glucose levels, improving estimates of glycaemic control in patients with diabetes, a study shows.

09-16-2016 | Continuous glucose monitoring | News | Article

Continuous glucose monitoring hopeful for hypoglycaemia unaware patients

The IN CONTROL trial demonstrates that continuous glucose monitoring improves glycaemic control in Type 1 diabetes patients who have hypoglycaemia unawareness.

09-15-2016 | Flash glucose monitoring | News | Article

‘Flash’ glucose sensor reduces glucose variability in Type 1 diabetes

“Flash” glucose monitoring reduces the time adults with Type 1 diabetes spend in a hypoglycaemic state by about a third, research shows.

Image Credits